Compound Summary
Compound Information
药名: | (-)-phaseollidin |
别名: | CHEBI:17556; AKOS032948450; CHEMBL508534; AC1Q70TS; 4CN-1496; (?)-phaseollidin; ZINC895662; Phaseollidin; BDBM50311583; DTXSID50191270; AC1L3OI5; SCHEMBL1545850; Phaseolidin; LMPK12070011; MolPort-023-298-969; 37831-70-2; BG01036204; 6H-Benzofuro(3,2-c)(1)benzopyran-3,9-diol, 6a,11a-dihydro-10-(3-methyl-2-butenyl)-, (6aR,11aR)-; Phaseollidin; (6aR,11aR)-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol; (6aR,11aR)-10-(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol; 6h-benzofuro(3,2-c)(1)benzopyran-3,9-diol, 6a,11a-dihydro-10-(3-methyl-2-butenyl)-,(6ar-cis)-; (-)-Phaseollidin; 6H-Benzofuro(3,2-c)(1)benzopyran-3,9-diol, 6a,11a-dihydro-10-(3-methyl-2-butenyl)-, (6aR-cis)-; D0A9CZ; 6H-Benzofuro[3,2-c][1]benzopyran-3,9-diol,6a,11a-dihydro-10-(3-methyl-2-buten-1-yl)-, (6aR,11aR)-; W2071; C05230; 6H-Benzofuro(3,2-c)(1)benzopyran-3,9-diol, 6a,11a-dihydro-10-(3-methyl-2-butenyl)-, (6aR-cis)-; (-)-Phaseollidin; (6aR,11aR)-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-benzofurano[3,2-c]chromene-3,9-diol; CHEBI:17556; 37831-70-2; (6aR,11aR)-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzoxolo[3,2-c]chromene-3,9-diol; 6H-Benzofuro(3,2-c)(1)benzopyran-3,9-diol, 6a,11a-dihydro-10-(3-methyl-2-butenyl)-, (6aR,11aR)-; phaseollidin; C05230; (6aR,11aR)-10-(3-methylbut-2-en-1-yl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol |
分子式: | C20H20O4 |
Smiles: | CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C=CC(=C4)O)O)C |
成分: | HBIN039413; HBIN039414; HBIN039412 |
OB_score: | 52.042722 |
CAS_id: | 37831-70-2 |
SymMap_id: | SMIT19418; SMIT03057 |
TCMID_id: | 31778; 17033 |
TCMSP_id: | MOL000457 |
PubChem_id: | 119268 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE002715 | Semen Phaseoli Radiati | 绿豆 | 1. To clear heat and toxic materials, clear summer-heat and promote diuresis. 2. To relieve the metallic and drug poisoning. 3. External use for clearing away heat and promoting tissue regeneration. 4. To reduce the level of blood-fat./1. Diuretic. 2. Its coat exerts a bacteriostatic effect on staphylococcus. | |||
| TCMBANKHE003814 | Semen Pharbitidis | 牵牛子 | To cause drastic purgation for clearing away retained fluid, and to kill worms./Edema distention fullness, inhibited urine and stool, phlegm-rheum and accumulation-gathering, qi counterflow with cough and asthma, abdominal pain due to worm accumulation, ascariasis, taeniasis. | |||
| TCMBANKHE003923 | Lablab niger | 扁豆 | 1. Treatment of deficient spleen not transforming and transporting water manifested as lassitude, poor appetite, loose stool or diarrhea, or leukorrhea due to downward flowing of turbid dampness. Hyacinth bean (Biandou) is used with Ginseng (Renshen), White atractylodes (Baizhu) and Poria (Fuling) in the formula Shen Ling Baizhu San. 2. Treatment of disharmony of the spleen and stomach due to invasion from exogenous pathogenic summer-damp-heat manifested as vomiting and diarrhea. Hyacinth bean (Biandou) is used with Elsholtzia (Xiangru) and Magnolia bark (Houpo) in the formula Xiangru San./Containing phytoagglutintin, trypsin and amylase inhibitors. | |||
| TCMBANKHE005743 | Lablab niger | 扁豆 | 1. Treatment of deficient spleen not transforming and transporting water manifested as lassitude, poor appetite, loose stool or diarrhea, or leukorrhea due to downward flowing of turbid dampness. Hyacinth bean (Biandou) is used with Ginseng (Renshen), White atractylodes (Baizhu) and Poria (Fuling) in the formula Shen Ling Baizhu San. 2. Treatment of disharmony of the spleen and stomach due to invasion from exogenous pathogenic summer-damp-heat manifested as vomiting and diarrhea. Hyacinth bean (Biandou) is used with Elsholtzia (Xiangru) and Magnolia bark (Houpo) in the formula Xiangru San./Containing phytoagglutintin, trypsin and amylase inhibitors. | |||
| TCMBANKHE005105 | Vigna unguiculata | 豇豆 | To fortify spleen and disinhibit damp, supplement kidney and rough essence./Spleen-stomach vacuity, diarrhea and dysentery, vomiting of sour matter, kidney vacuity lumbago, emission, diabetes mellitus, leukorrhea, white turbidity, frequent urination. | |||
| TCMBANKHE008910 | Semen Pharbitidis | 牵牛子 | To cause drastic purgation for clearing away retained fluid, and to kill worms./Edema distention fullness, inhibited urine and stool, phlegm-rheum and accumulation-gathering, qi counterflow with cough and asthma, abdominal pain due to worm accumulation, ascariasis, taeniasis. | |||
| TCMBANKHE008315 | Cortex erythrie | 海桐皮 | 1. To dispel wind and dampness; 2. To clear the meridians/Wind-damp impediment, pain in lumbus and knees, scab sore, lichen, eczema. |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000181 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase |
| TCMBANKGE000201 | ESR1 | ER; ESR; ESRA; ESTRR; Era; NR3A1 | estrogen receptor 1 |
| TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
| TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
| TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
| TCMBANKGE000360 | CCNA2 | CCN1; CCNA | cyclin A2 |
| TCMBANKGE000476 | NCOA2 | GRIP1; KAT13C; NCoA-2; SRC2; TIF2; bHLHe75 | nuclear receptor coactivator 2 |
| TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
| TCMBANKGE000633 | ADRB2 | ADRB2R; ADRBR; B2AR; BAR; BETA2AR | adrenoceptor beta 2 |
| TCMBANKGE000701 | ESR2 | ER-BETA; ESR-BETA; ESRB; ESTRB; Erb; NR3A2; ODG8 | estrogen receptor 2 |
| TCMBANKGE000784 | CALM3 | CALM; CAM1; CAM2; CAMB; CPVT6; CaM; CaMIII; HEL-S-72; LQT16; PHKD; PHKD3 | calmodulin 3 |
| TCMBANKGE000813 | DPP4 | ADABP; ADCP2; CD26; DPPIV; TP103 | dipeptidyl peptidase 4 |
| TCMBANKGE000938 | CDK2 | CDKN2; p33(CDK2) | cyclin dependent kinase 2 |
| TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
| TCMBANKGE001185 | PPARG | CIMT1; GLM1; NR1C3; PPARG1; PPARG2; PPARG5; PPARgamma | peroxisome proliferator activated receptor gamma |
| TCMBANKGE001202 | MAPK14 | CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; p38ALPHA | mitogen-activated protein kinase 14 |
| TCMBANKGE004266 | AR | AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM | androgen receptor |
| TCMBANKGE008921 | RXRA | NR2B1 | retinoid X receptor alpha |
| TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
滇ICP备16009434号-1 |
Dai SX Lab